These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3003404)

  • 1. Solubility of calcium oxalate monohydrate and hydroxyapatite in EDTA solutions.
    Verplaetse H; Verbeeck RM; Verbaeys A; Oosterlinck W
    J Urol; 1986 Mar; 135(3):608-11. PubMed ID: 3003404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solubility of inorganic kidney stone components in the presence of acid-base sensitive complexing agents.
    Verplaetse H; Verbeeck RM; Minnaert H; Oosterlinck W
    Eur Urol; 1985; 11(1):44-51. PubMed ID: 2985396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epitaxial considerations in urinary stone formation. I. The urate-oxalate-phosphate system.
    Koutsoukos PG; Lam-Erwin CY; Nancollas GH
    Invest Urol; 1980 Sep; 18(2):178-84. PubMed ID: 7410035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro dissolution of calcium oxalate stones with ethylenediaminetetraacetic acid and snake venom thrombin-like enzyme.
    Zhou XJ; Zhang J; Zhang C; Xu CG
    Urol Int; 2014; 92(3):349-55. PubMed ID: 24246673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of dissolution of calcium oxalate calculi with calcium-chelating irrigating solutions.
    Burns JR; Cargill JG
    J Urol; 1987 Mar; 137(3):530-3. PubMed ID: 3102759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening of chelating agents for chemolysis.
    Verplaetse H; Verbeeck RM; Minnaert H; Oosterlinck W
    Eur Urol; 1986; 12(3):190-4. PubMed ID: 3709589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemolysis of calcium containing urinary calculi. A review.
    Oosterlinck W; Verbeeck R
    Acta Urol Belg; 1994 Jun; 62(2):31-7. PubMed ID: 8037001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epitaxial relationships in urolithiasis: the calcium oxalate monohydrate-hydroxyapatite system.
    Meyer JL; Bergert JH; Smith LH
    Clin Sci Mol Med; 1975 Nov; 49(5):369-74. PubMed ID: 1192695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of hydroxyapatite and pyrophosphate on the formation product of calcium oxalate at different pHs.
    Baumann JM; Ackermann D; Affolter B
    Urol Res; 1989; 17(3):153-5. PubMed ID: 2546312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleation kinetics in the calcium oxalate-sodium urate monohydrate system.
    Meyer JL
    Invest Urol; 1981 Nov; 19(3):197-201. PubMed ID: 7298292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Search for a new rinsing solution for the local lysis of calcium-containing urinary calculi].
    Leskovar P; Hropot M; Wellnhofer E
    Z Urol Nephrol; 1982 Apr; 75(4):245-52. PubMed ID: 7102135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical manifestations of calcium oxalate monohydrate and dihydrate urolithiasis.
    Koide T; Itatani H; Yoshioka T; Ito H; Namiki M; Nakano E; Okuyama A; Takemoto M; Sonoda T
    J Urol; 1982 Jun; 127(6):1067-9. PubMed ID: 7087010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of phosphate to formation of calcium oxalate urinary calculi.
    Sun XZ; Zhang YS
    Acta Acad Med Wuhan; 1984; 4(2):100-4. PubMed ID: 6738980
    [No Abstract]   [Full Text] [Related]  

  • 14. Uropontin in urinary calcium stone formation.
    Hoyer JR
    Miner Electrolyte Metab; 1994; 20(6):385-92. PubMed ID: 7783701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Basic studies of citrate therapy on urolithiasis--the effect of citrate on solubility of calcium oxalate crystal and on calcium deposition of murine kidney in experimental oxalate stone].
    Yasukawa S
    Nihon Hinyokika Gakkai Zasshi; 1988 Apr; 79(4):613-9. PubMed ID: 3226013
    [No Abstract]   [Full Text] [Related]  

  • 16. Urothelial injury to the rabbit bladder caused by calcium dissolving agents including two new citrate solutions.
    Zhang XB; Wang ZP; Duan JM; Duan GL; Shi TK; Lu JZ; Ma BL
    Urol Res; 2005 Aug; 33(4):309-13. PubMed ID: 16003533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The influence of uric acid on the calcium oxalate stone formation (author's transl)].
    Matouschek E; Huber R
    Urologe A; 1979 Jul; 18(4):211-4. PubMed ID: 38552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic Analysis after Sequential Extraction of Matrix Proteins in Urinary Stones Composed of Calcium Oxalate Monohydrate and Calcium Oxalate Dihydrate.
    Kaneko K; Nishii S; Izumi Y; Yasuda M; Yamanobe T; Fukuuchi T; Yamaoka N; Horie S
    Anal Sci; 2015; 31(9):935-42. PubMed ID: 26353961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of an in vitro assay for the screening of substances capable of dissolving calcium oxalate crystals.
    Saso L; Valentini G; Leone MG; Grippa E; Silvestrini B
    Urol Int; 1998; 61(4):210-4. PubMed ID: 10364751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrence of renal lithiasis.
    Grases F; Costa-Bauzá A; Ramis M; Montesinos V; Conte A
    Scand J Urol Nephrol; 2003; 37(6):482-6. PubMed ID: 14675921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.